Gs Investments, Inc. Amgen Inc Transaction History

Gs Investments, Inc.

  • $221 Million
  • Q4 2024

A detailed history of Gs Investments, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Gs Investments, Inc. holds 10,957 shares of AMGN stock, worth $3.42 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares
10,957
Previous 11,383 3.74%
Holding current value
$3.42 Million
Previous $3.67 Million 22.14%
% of portfolio
1.29%
Previous 1.64%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$258.78 - $328.31 $110,240 - $139,860
-426 Reduced 3.74%
10,957 $2.86 Million
Q3 2024

Nov 12, 2024
SELL
$309.38 - $337.38 $3,093 - $3,373
-10 Reduced 0.09%
11,383 $3.67 Million
Q2 2024

Jul 31, 2024
SELL
$262.75 - $319.31 $9,459 - $11,495
-36 Reduced 0.31%
11,393 $3.56 Million
Q1 2024

May 09, 2024
BUY
$268.87 - $324.56 $38,448 - $46,412
143 Added 1.27%
11,429 $3.25 Million
Q4 2023

Feb 08, 2024
BUY
$255.7 - $288.46 $8,949 - $10,096
35 Added 0.31%
11,286 $3.25 Million
Q3 2023

Nov 01, 2023
SELL
$218.65 - $271.46 $37,170 - $46,148
-170 Reduced 1.49%
11,251 $3.02 Million
Q2 2023

Aug 04, 2023
SELL
$214.27 - $253.37 $3,214 - $3,800
-15 Reduced 0.13%
11,421 $2.54 Million
Q4 2022

Feb 07, 2023
BUY
$229.03 - $291.01 $5,725 - $7,275
25 Added 0.22%
11,436 $3 Million
Q3 2022

Nov 10, 2022
SELL
$224.46 - $253.15 $4,713 - $5,316
-21 Reduced 0.18%
11,411 $2.57 Million
Q2 2022

Aug 03, 2022
SELL
$230.71 - $256.74 $6,921 - $7,702
-30 Reduced 0.26%
11,432 $2.79 Million
Q1 2022

Apr 26, 2022
BUY
$219.27 - $242.57 $24,119 - $26,682
110 Added 0.97%
11,462 $2.89 Million
Q4 2021

Feb 09, 2022
SELL
$198.88 - $227.6 $17,899 - $20,484
-90 Reduced 0.79%
11,352 $2.55 Million
Q3 2021

Nov 12, 2021
BUY
$212.27 - $248.7 $2.43 Million - $2.85 Million
11,442 New
11,442 $2.43 Million
Q1 2021

May 07, 2021
SELL
$221.91 - $258.6 $1.4 Million - $1.63 Million
-6,290 Closed
0 $0
Q4 2020

Feb 10, 2021
BUY
$216.38 - $257.67 $1.36 Million - $1.62 Million
6,290 New
6,290 $1.45 Million
Q3 2020

Nov 12, 2020
SELL
$234.65 - $260.95 $2.75 Million - $3.05 Million
-11,700 Closed
0 $0
Q2 2020

Aug 12, 2020
SELL
$197.81 - $242.74 $12,462 - $15,292
-63 Reduced 0.54%
11,700 $2.76 Billion
Q1 2020

May 07, 2020
SELL
$182.24 - $241.7 $23,508 - $31,179
-129 Reduced 1.08%
11,763 $2.38 Billion
Q4 2019

Feb 04, 2020
SELL
$189.21 - $243.2 $77,765 - $99,955
-411 Reduced 3.34%
11,892 $2.2 Billion
Q3 2019

Nov 01, 2019
SELL
$174.11 - $208.62 $67,902 - $81,361
-390 Reduced 3.07%
12,303 $2.38 Billion
Q2 2019

Aug 09, 2019
BUY
$166.7 - $195.41 $55,844 - $65,462
335 Added 2.71%
12,693 $2.34 Billion
Q1 2019

Apr 26, 2019
BUY
$180.87 - $203.88 $1,808 - $2,038
10 Added 0.08%
12,358 $2.35 Billion
Q4 2018

Feb 07, 2019
BUY
$178.4 - $208.25 $2,676 - $3,123
15 Added 0.12%
12,348 $2.4 Billion
Q3 2018

Nov 06, 2018
BUY
$185.29 - $208.89 $31,684 - $35,720
171 Added 1.41%
12,333 $2.56 Billion
Q2 2018

Aug 10, 2018
SELL
$166.05 - $186.51 $87,176 - $97,917
-525 Reduced 4.14%
12,162 $2.24 Billion
Q1 2018

May 15, 2018
BUY
$169.43 - $198.0 $42,357 - $49,500
250 Added 2.01%
12,687 $2.16 Billion
Q4 2017

Feb 13, 2018
BUY
$168.79 - $188.59 $16,035 - $17,916
95 Added 0.77%
12,437 $2.16 Billion
Q3 2017

Nov 07, 2017
BUY
$167.29 - $191.0 $6,357 - $7,258
38 Added 0.31%
12,342 $2.3 Billion
Q2 2017

Aug 29, 2017
BUY
N/A
12,304
12,304 $2.12 Billion

Others Institutions Holding AMGN

# of Institutions
3,173
Shares Held
419M
Call Options Held
8.25M
Put Options Held
6.39M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gs Investments, Inc. Portfolio

Follow Gs Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gs Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gs Investments, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email